Prolonged survival in a Patient with Chronic Myeloid Leukemia
oleh: Ashutosh Shukla, O P Kalra
| Format: | Article |
|---|---|
| Diterbitkan: | Nepal Medical Association 2013-04-01 |
Deskripsi
Patients with chronic myeloid leukemia treated with intermittent busulphan therapy have an average survival rate of 2 to 4 years. The authors report here a patient who continues to survive beyond one decade on busulphan therapy.